IDiyas

For the Inventor, By the Inventor

Koshigaya, Japan

Masaru Satoh

USPTO Granted Patents = 10

Average Co-Inventor Count = 5.7

ph-index = 2

Forward Citations = 18(Granted Patents)


Company Filing History:

goldMedal10 out of 132 
 
Nippon Chemiphar Co., Ltd.
 patents

Years Active: 1987-1995

Loading Chart...
10 patents (USPTO):Explore Patents
1. 5446146 - Piperazine derivative having substituted phenyl groups (1995-08-29),
2. 5310902 - Alkylenediamine derivatives (1994-05-10),
3. 5250546 - Amino-alcohol derivatives and processes for their preparation (1993-10-05),
4. 5106976 - Fused pyrazine sulfoxide derivatives for use as antiulcer agents (1992-04-21),
5. 5070196 - Alkylenediamine derivatives (1991-12-03),
6. 5070089 - Therapeutic agent for liver disease and piperazine derivatives (1991-12-03),
7. 4933458 - Certain gastric acid secretion inhibiting sulfoxides (1990-06-12),
8. 4824856 - Method of protecting gastrointestinal tract (1989-04-25),
9. 4764617 - Quinaldinamide derivatives (1988-08-16),
10. 4644063 - 1,3-oxazolidine-2-one derivatives (1987-02-17),

Title: Masaru Satoh: Innovator in Pharmaceutical Chemistry

Introduction

Masaru Satoh is a prominent inventor based in Koshigaya, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of therapeutic agents. With a total of 10 patents to his name, Satoh's work has the potential to impact the treatment of various diseases.

Latest Patents

Among his latest patents, Satoh has developed a piperazine derivative that serves as a therapeutic agent for liver disease. This compound features a unique formula that includes substituted phenyl groups, which may have various functional groups. Additionally, he has created novel alkylenediamine derivatives that effectively act as glutamate blockers. These derivatives are characterized by their complex structures, which include aliphatic hydrocarbon groups and various substituents.

Career Highlights

Satoh is currently employed at Nippon Chemiphar Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has garnered attention for its potential applications in treating liver diseases and neurological conditions.

Collaborations

Throughout his career, Satoh has collaborated with notable colleagues, including Mitsuo Masaki and Tomio Yamakawa. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Masaru Satoh's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a key inventor in the field. His work continues to pave the way for new therapeutic options in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…